Skip to main content
. 2021 Sep 7;10(9):1149. doi: 10.3390/pathogens10091149
AE Adverse events
AH Arterial hypertension
AKI Acute kidney injury
CDC Centers for Disease Control and Prevention
CI Confidence intervals
CKD Chronic kidney disease
DAAs Direct-acting antiviral agents
DM Diabetes mellitus
ESA Erythropoietin-stimulating agents
ESRD End-stage renal disease
HBV Hepatitis B virus
HCV Hepatitis C virus
HIV Human immunodeficiency virus
HR Hazard ratio
HD Hemodialysis
KDIGO Kidney Disease: Improving Global Outcomes
NA Not available
OR Odds ratio